Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cv Sciences Inc (OP:CVSI)

0.0368 -0.0010 (-2.65%)
Streaming Delayed Price Updated: 12:42 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cv Sciences Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
CBD And Nicotine Formula To Treat Smokeless Tobacco Addiction Receives Patent From Japan, FDA Approval Next
CV Sciences, Inc. (OTCQB: CVSI) received a formal certificate of grant from the Japan Patent Office for its patent application 7216697. 
Via Benzinga
Why Is CV Sciences Stock Up Today?
CV Sciences (OTCQB: CVSI) shares were trading 10.69% higher at $0.044 per share at the time of writing Monday morning on company's third-quarter financial results. 
Via Benzinga
Biden's Pardon For Cannabis Offenders: 27 Reactions From Politicians, Industry Executives And Advocacy Orgs
President Joe Biden announced on Thursday that he will pardon all prior federal offenses for simple marijuana possession, sending  
Via Benzinga
The CBD Gold Rush Is Over (And That's A Great Thing For Consumers)
By Bharat Ayyar Disclaimer: I am not a financial advisor. Nothing contained in this post should be construed as investment advice. CV Sciences (OTC: CVSI), the company behind +PlusCBD, had a meteoric... 
Via Benzinga
Marijuana As An Appetite Suppressant? It's A Possibility
Using cannabis as an appetite suppressant for weight management may seem counterintuitive, but one rare cannabinoid may have just that effect. Delta-9 (d-9)-dominant tetrahydrocannabivarin (THCV) has... 
Via Benzinga
CV Sciences Adds +PlusCBD Relief Softgels To Wellness Line Of CBD Products
CV Sciences, Inc. (OTCQB:CVSI) added +PlusCBD ... 
Via Benzinga
Nutrition Giant GNC To Distribute CBD Products In 770 Stores In US
Hemp cannabidiol (CBD) products maker CV Sciences, Inc. (OTCQB: 
Via Benzinga
CV Sciences Q1 Revenue Down 8.33%, CEO Encouraged As PlusCBD Brand Gains Market Share
CV Sciences, Inc. (OTCQB: CVSI) released its financial results for the quarter ended March 31, 2022, revealing a revenue drop of 8.33% to $4.4 million YoY. First Quarter 2022 and Recent Financial and... 
Via Benzinga
A Preview Of CV Sciences's Earnings
CV Sciences (OTC:CVSI) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that CV Sciences will... 
Via Benzinga
Dry January Got You Down? Cannabis To The Rescue With Tokes, Yummy Gummies And More
After the hustle and bustle of the holidays, many people are looking to curtail their consumption of alcohol and are therefore partaking in 
Via Benzinga
CV Sciences Launches +PlusCBD Pain Relief Topicals With Products For Athletes, Arthritis Patients
CV Sciences, Inc. (OTCQB:CVSI) is launching +PlusCB... 
Via Benzinga
Is Medical Marijuana Really A Slippery Slope? CVSI Distribution Agreement with GNC
The Best Daily Overview Of The Cannabis Space CV Sciences Announces New Distribution Agreement with GNC. $CVSI ... 
Via Benzinga
Trending Up: $TLLTF $VRNOF $UNRV, GOP Cannabis Bill, Cause for Hope? — Cannabis Daily November 16, 2021
The Best Daily Overview Of The Cannabis Space Representativ... 
Via Benzinga
Topics Cannabis
The Week In Cannabis: Stocks Down, Republican Legalization Bill, Germany, Uruguay, Earnings, New ETF And More
Below is a recap of the main news related to the cannabis industry and markets for the week of November 15, 2021. 
Via Benzinga
Topics Cannabis
CV Sciences 3Q Financials Continue To Improve Cost Structure, Praises California CBD Legislation
CV Sciences, Inc. (OTCQB:CVSI), a supplier and manufacturer... 
Via Benzinga
Topics Supply Chain
Earnings Preview For CV Sciences
CV Sciences (OTC:CVSI) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
Pharmaceutical & Hemp Wellness Segments Of Cannabidiol Market Could See the Fastest Growth Rates Through 2028
Palm Beach, FL – November 15, 2021 – FinancialNewsMedia.com News Commentary – Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects.... 
Via FinancialNewsMedia
EXCLUSIVE: CV Sciences Launches New Product Line Featuring Full Range Of Phytocannabinoids
CV Sciences Inc (OTC:CVSI) is launching a ne... 
Via Benzinga
Looking Into CV Sciences's Return On Capital Employed
CV Sciences (OTC:CVSI) brought in sales totaling $5.13 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 12.75%, resulting in a loss of $3.... 
Via Benzinga
Ryder Cup To Retirees: Many Golfers Say CBD Is A Hole In One For Their Game
Professional golf is one of, if not the most cannabis-friendly globally played sports today. While Olympians and athletes in other sports cont... 
Via Benzinga
Cantor Remains Neutral on Charlotte's Web, cbdMD and CV Science CBD Stocks, Sector Could Benefit From Federal Legalization
Cantor Fitzgerald released a new report analyzing the possible effects of CBD reform in the stock performance of Charlotte... 
Via Benzinga
American Cannabis Operator Index Lost 0.6% This Year, Best Players In July: Columbia Care, Lowell Farms, Ayr Wellness & Ascend Wellness
The American Cannabis Operator Index declined for the fifth straight month falling 10.7% to 62.66. The index, which launched in Oc... 
Via Benzinga
Topics Cannabis
Slight Correction For Cannabis Stocks After A Ramping Week, Check Out The Top Movers For July 30, 2021
GAINERS: Rhinomed (OTC: 
Via Benzinga
Topics Cannabis
The Week In Cannabis: Amazon Lobbies In DC, Colombia's New Law, Big IPOs And More
Below is a recap of the main news related to the cannabis industry and markets for the week of July 16, 2021. 
Via Benzinga
Topics Cannabis
Watch Planet 13's CEO & Matt Hawkins From Entourage Effect Capital At Benzinga Cannabis Hour 7/21
Benzinga’s Cannabis Hour is a live show for cannabis investors. On Thursday's show, hosts Elliot L... 
Via Benzinga
Topics Cannabis
CBD Can Reduce Nicotine Withdrawal Symptoms, Says New Study Done By CV Sciences
This week, CV Sciences (OTCQB:CVSI) released the results of... 
Via Benzinga
Australis, CV Sciences And MedMen Among Top Cannabis Stock Movers On July 9, 2021
GAINERS: Livewell Canada Inc (OTC: 
Via Benzinga
Topics Cannabis
Watch CV Sciences & Lyphe Group On The Benzinga Cannabis Hour
Benzinga’s Cannabis Hour is a live show for cannabis investors. On Thursday’s show, hosts Elliot Lane... 
Via Benzinga
Topics Cannabis
Cannabis Stock Gainers And Losers From June 21, 2021
GAINERS: Mexco Energy (AMEX: 
Via Benzinga
Topics Cannabis
Cantor Updates Ratings On Several Cannabis And CBD Stocks - MedMen, Jushi, cbdMD, CV Sciences
Cantor Fitzgerald’s Pablo Zuanic provided updated ratings and estimates on several stocks from the cannabis and CBD sector, those being ... 
Via Benzinga
Topics Cannabis
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.